top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Adipokines 2.0
Adipokines 2.0
Autore Büchler Christa
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (406 p.)
Soggetto non controllato lipids
cathepsins
neurodegeneration
tocilizumab
SGBS adipocytes
chemerin receptors
cholesterol
metabolically healthy obese
energy metabolism
adipose-brain axis
EP3 receptor
leptin
rheumatoid arthritis
excessive gestational weight gain
in vitro fat regain
secreted frizzled-related protein 5
PCOS
EP4 receptor
leukocyte
exchange protein directly activated by cAMP isoform 2 (EPAC2)
extracellular remodeling
insulin
osteoarthritis
lipid metabolism
fat mass
Tango bioassay
fatty liver
free fatty acids
label-free proteomic profiling
interleukin(IL)-33
sick fat
polycystic ovary syndrome
early-life programming
inflammation
gestational diabetes
glucose restriction
adipokines
neonatal anthropometry
epicardial adipose tissue (EAT)
oestrous cycle
Cardiovascular Diseases (CVDs)
triglycerides
G protein-coupled receptor 1
testicular pathologies
prognosis
ovary
ICU
biologic activity
preeclempsia
adipokine
critical illness
early pregnancy
myokine
liver steatosis
C-C chemokine receptor-like 2
testis
stimulating growth factor 2 (ST2)
pig
fitness
human granulosa cells
obesity
proteolysis
annexins
adipose tissue
biomarker
ghrelin
brain health
sepsis
adiponectin
rheumatic diseases
chemokine-like receptor 1
follicular fluid
glucose homeostasis
resistin
Nonalcoholic fatty liver disease
prostaglandin E2 (PGE2)
visceral fat
microglia
weight regain
complement factors
alpha-fetoprotein
polycystic ovary morphology
chemerin
cancer
depression
hypertension
hypothalamus
ISBN 3-03928-587-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910404092003321
Büchler Christa  
MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
New Therapies of Liver Diseases
New Therapies of Liver Diseases
Autore Toniutto Pierluigi
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (236 p.)
Soggetto topico Public health & preventive medicine
Soggetto non controllato tolvaptan
cirrhotic ascites
survival rate
furosemide
primary biliary cholangitis
autoantibodies
ursodeoxycholic acid
treatment response
second line therapy
primary biliary cholangitis (PBC)
primary sclerosing cholangitis (PSC)
clinical trials
ursodeoxycholic acid (UDCA)
Farnesoid X Receptor (FXR) agonist
Pan-Peroxisome Proliferator-Activated Receptor (PPAR) agonists
liver cancer
systemic treatment
immunotherapy
real-world
unresectable hepatocellular carcinoma
cirrhosis
decompensation
bleeding
varices
survival
infection
alcoholic hepatitis
acute-on-chronic liver failure
cholangiocarcinoma
colorectal cancer metastases
hepatocellular carcinoma
liver transplantation
Milan criteria
alpha-fetoprotein
solid organ transplantation
liver injury
immunosuppressant
SARS-CoV-2
humoral response
vaccination
portal-systemic shunt
ammonia
vigilance
HBV
HDV
antivirals
functional cure
pharmacology
acute-on-chronic liver failure (ACLF)
liver transplantation (LT)
decompensated cirrhosis
portal hypertension
ascites
non-selective beta-blockers
TIPS
rifaximin
human albumin
statins
targeted therapy
effective hypovolemia
anti-mineralocorticoids
loop diuretics
vaptans
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566457403321
Toniutto Pierluigi  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui